WELCOME TO THE BrILliance CLINICAL STUDY!

BrILliance aims to find out whether a study drug is safe and effective in patients with advanced solid tumors.

Are you seeking options for advanced solid tumors?

This website provides information about a clinical study, BrILliance, for patients with advanced solid tumors. BrILliance is a phase 1/2 clinical research study that aims to assess the safety, tolerability, and efficacy of a study drug in people who have advanced solid tumors.

Clinical studies are essential to investigating potential treatments and are not possible without the people who take part. Everyone involved in this clinical study plays an important role in increasing our understanding of advanced solid tumors, which may help others in the future with this condition.

Living with advanced cancer may feel overwhelming, and you may feel that you have enough to do without committing to a clinical study. However, you may play a key role in helping to develop therapies that are being studied to help advance our medical knowledge of solid tumors. Every treatment that exists today is available because of study participants who actively took part in research.

Learn more about BrILliance and see if it may be an option for you or someone you know.